HHC: Difference between revisions

(One intermediate revision by one other user not shown)

Line 2:

Hexahydrocannabinol (HHC) is a [[cannabinoid]] analogue that has been marketed as an "alternative cannabinoid" since 2021. It is a saturated cannabinoid, meaning it has no double bonds in its chemical structure, which differentiates it from other cannabinoids such as THC. The mechanism of action is [[Agonist|binding activity]] at [[cannabinoid]] [[receptors]] distributed throughout the body.

'''Hexahydrocannabinol''' ('''HHC''') is a [[cannabinoid]] analogue that has been marketed as an "alternative cannabinoid" since 2021. It is a saturated cannabinoid, meaning it has no double bonds in its chemical structure, which differentiates it from other cannabinoids such as THC. The mechanism of action is [[Agonist|binding activity]] at [[cannabinoid]] [[receptors]] distributed throughout the body.

=== Chemistry ===

@@ Line 2: / Line 2: @@
 {{SubstanceBox/HHC}}
-Hexahydrocannabinol (HHC) is a [[cannabinoid]] analogue that has been marketed as an "alternative cannabinoid" since 2021. It is a saturated cannabinoid, meaning it has no double bonds in its chemical structure, which differentiates it from other cannabinoids such as THC. The mechanism of action is [[Agonist|binding activity]] at [[cannabinoid]] [[receptors]] distributed throughout the body.
+'''Hexahydrocannabinol''' ('''HHC''') is a [[cannabinoid]] analogue that has been marketed as an "alternative cannabinoid" since 2021. It is a saturated cannabinoid, meaning it has no double bonds in its chemical structure, which differentiates it from other cannabinoids such as THC. The mechanism of action is [[Agonist|binding activity]] at [[cannabinoid]] [[receptors]] distributed throughout the body.
 === Chemistry ===